[c09aa8]: / clusters / 9knumclustersv2 / clust_533.txt

Download this file

89 lines (88 with data), 5.1 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
Subject has adequate organ and marrow function.
. Adequate organ and marrow function;
Adequate bone marrow and organ function, as defined by the protocol
Adequate organ and bone marrow function:
Adequate organ and marrow function
Adequate organ and marrow function
Must have adequate organ and marrow function
Subjects with adequate organ and marrow function
Patients must have adequate organ and bone marrow function within days prior to registration, as defined below:
Adequate bone marrow and organ function
Adequate organ and marrow function as defined below:
Have adequate normal organ and marrow function, including the following:
Adequate organ function defined as: Bone Marrow:
Subject has adequate bone marrow and organ function as shown by:
Adequate organ and marrow function
Patients must have adequate organ and bone marrow function within days prior to registration, as defined by: leukocytes >= ,/mcL
Subjects with adequate organ and bone marrow function as defined below:
Patients must have adequate organ and marrow function as determined by the treating oncologist
Adequate organ and bone marrow function
Subjects must have adequate organ and marrow at screening as defined below:
Patients must have adequate organ and bone marrow function =< days prior to registration, as defined below:
The patient has adequate organ and marrow function per protocol
Adequate organ and marrow function
Patients must have adequate bone marrow and organ function.
Adequate normal organ and marrow function
Adequate organ and bone marrow function defined by routine testing
Adequate organ and marrow function as determined by medical oncology evaluation
Adequate bone marrow and organ function
Adequate organ and marrow function
Adequate organ and bone marrow function
Adequate normal organ and marrow function as defined below (must be done within days prior to enrolment):
Adequate organ and marrow function
Adequate bone marrow and organ function as assessed by the laboratory tests performed within days before of treatment initiation.
Adequate organ and marrow function, defined per protocol
Adequate bone marrow and organ function
Adequate organ and marrow function
Adequate organ and marrow function
Adequate organ and bone marrow function determined within days prior to enrollment defined as:
Subjects must have adequate organ and marrow function as defined below:
Adequate organ and marrow function
Patient has adequate bone marrow and organ function
Adequate organ and marrow function
Patient has adequate bone marrow and organ function
Adequate organ and marrow function, resolution of all toxic effects of prior therapy or surgical procedures
Adequate organ and marrow function
Patients must have adequate organ and bone marrow function
Patients must have adequate organ and bone marrow function within days prior to registration, as defined below:
Life expectancy ? weeks. . ECOG PS of or . Adequate organ and bone marrow function . Ability to undergo during screening a tumor biopsy that is adequate for biomarker analysis.
Adequate organ and bone marrow function within the days prior to randomization defined by:
Adequate organ and marrow function
Adequate bone marrow and organ function
Adequate organ and marrow function , as defined below:
Adequate bone marrow, organ function, cardiac and laboratory parameters
Adequate bone marrow, organ function, cardiac and laboratory parameters
Adequate organ and marrow function.
Have adequate organ and bone marrow function.
Adequate organ and marrow function.
Patients must have adequate organ and marrow function as defined below
Adequate organ and marrow function
Adequate bone marrow function and organ function
Patient has adequate bone marrow and organ function.
Adequate organ and marrow function
Adequate organ and marrow function
Adequate organ and marrow function
Adequate organ and marrow function
Adequate organ and marrow function
For all tumor types, adequate organ and marrow function, as defined below:
Adequate bone marrow and organ function
Patient has adequate bone marrow and organ function.
Adequate organ or bone marrow function
Adequate bone marrow and organ function
Adequate organ and marrow function:
Patient has adequate bone marrow and organ function
Adequate organ and marrow function
Adequate organ and bone marrow function
Adequate organ and marrow function
Adequate organ and bone marrow function as assessed by laboratory tests
Adequate bone marrow and organ function
Adequate bone marrow and organ function
Participants must have adequate organ and marrow function to proceed to transplant
Adequate bone marrow and organ function as determined by the consenting/enrolling investigator
Adequate organ and marrow function.
Patients must have adequate organ and bone marrow function days prior to registration, as defined below:
Adequate bone marrow and organ function as defined as:
Adequate organ function for patients receiving crizotinib therapy as defined by the following criteria: Bone marrow function
Adequate organ and bone marrow function
Adequate organ and bone marrow function
Adequate organ and marrow function